Christopher Bunka - Net Worth and Insider Trading
Christopher Bunka Net Worth
The estimated net worth of Christopher Bunka is at least $1 Million dollars as of 2024-11-13. Christopher Bunka is the CEO of Lexaria Bioscience Corp and owns about 489,455 shares of Lexaria Bioscience Corp (LEXX) stock worth over $1 Million. Christopher Bunka is also the 10% Owner of Enertopia Corp and owns about 3,707,833 shares of Enertopia Corp (ENRT) stock worth over $42,269. Details can be seen in Christopher Bunka's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Bunka has not made any transactions after 2022-10-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Bunka
Christopher Bunka Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Bunka owns 2 companies in total, including Lexaria Bioscience Corp (LEXX) , and Enertopia Corp (ENRT) .
Click here to see the complete history of Christopher Bunka’s form 4 insider trades.
Insider Ownership Summary of Christopher Bunka
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LEXX | Lexaria Bioscience Corp | 2022-10-13 | director & 10 percent owner & CEO |
| ENRT | Enertopia Corp | 2013-08-28 | director & Chairman and CEO |
Christopher Bunka Latest Holdings Summary
Christopher Bunka currently owns a total of 2 stocks. Among these stocks, Christopher Bunka owns 489,455 shares of Lexaria Bioscience Corp (LEXX) as of October 13, 2022, with a value of $1 Million and a weighting of 96.38%. Christopher Bunka also owns 3,707,833 shares of Enertopia Corp (ENRT) as of August 28, 2013, with a value of $42,269 and a weighting of 3.62%.
Latest Holdings of Christopher Bunka
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LEXX | Lexaria Bioscience Corp | 2022-10-13 | 489,455 | 2.30 | 1,125,747 |
| ENRT | Enertopia Corp | 2013-08-28 | 3,707,833 | 0.01 | 42,269 |
Holding Weightings of Christopher Bunka
Christopher Bunka Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Bunka has made a total of 2 transactions in Lexaria Bioscience Corp (LEXX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Lexaria Bioscience Corp is the acquisition of 38,500 shares on October 13, 2022, which cost Christopher Bunka around $78,540.
According to the SEC Form 4 filings, Christopher Bunka has made a total of 0 transactions in Enertopia Corp (ENRT) over the past 5 years. The most-recent trade in Enertopia Corp is the acquisition of 274,000 shares on August 28, 2013, which cost Christopher Bunka around $5,480.
Insider Trading History of Christopher Bunka
- 1
Christopher Bunka Trading Performance
GuruFocus tracks the stock performance after each of Christopher Bunka's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Bunka is 16.06%. GuruFocus also compares Christopher Bunka's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Bunka within 3 months outperforms 68 times out of 115 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Bunka's insider trading performs compared to the benchmark.
Performance of Christopher Bunka
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.22 | | | | | |
| Relative Return to S&P 500(%) | 13.47 | | | | | |
Christopher Bunka Ownership Network
Ownership Network List of Christopher Bunka
Ownership Network Relation of Christopher Bunka
Christopher Bunka Owned Company Details
What does Lexaria Bioscience Corp do?
Who are the key executives at Lexaria Bioscience Corp?
Christopher Bunka is the director & 10 percent owner & CEO of Lexaria Bioscience Corp. Other key executives at Lexaria Bioscience Corp include Secretary Vanessa Carle , Chief Financial Officer Gregory Downey , and CFO Allan Horst Spissinger .
Lexaria Bioscience Corp (LEXX) Insider Trades Summary
Over the past 18 months, Christopher Bunka made no insider transaction in Lexaria Bioscience Corp (LEXX). Other recent insider transactions involving Lexaria Bioscience Corp (LEXX) include a net sale of 2,567 shares made by Vanessa Carle , and a net purchase of 1,600 shares made by Catherine C. Turkel .
In summary, during the past 3 months, insiders sold 0 shares of Lexaria Bioscience Corp (LEXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,567 shares of Lexaria Bioscience Corp (LEXX) were sold and 1,600 shares were bought by its insiders, resulting in a net sale of 967 shares.
Lexaria Bioscience Corp (LEXX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexaria Bioscience Corp Insider Transactions
Christopher Bunka Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Bunka. You might contact Christopher Bunka via mailing address: 1924 Birkdale Ave, Kelowna A1 V1p1r7.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
